Loading clinical trials...
Loading clinical trials...
Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors: Assessment of Safety and Efficacy
Conditions
Interventions
Terbium 161
Locations
2
India
Tata Memorial Hospital, Mumbai, India
Mumbai, Maharashtra, India
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
Navi Mumbai, Maharashtra, India
Start Date
March 1, 2026
Primary Completion Date
February 28, 2028
Completion Date
February 28, 2029
Last Updated
February 11, 2026
NCT03206060
NCT07536087
NCT06228066
NCT05746208
NCT07129252
NCT07369505
Lead Sponsor
Tata Memorial Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions